Fairmount Funds Management LLC Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Fairmount Funds Management LLC

  • $615 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 09, 2022
SELL
$144.95 - $152.29 $8.62 Million - $9.06 Million
-59,463 Reduced 22.51%
204,743 $31 Million
Q2 2022

Aug 15, 2022
BUY
$83.14 - $145.99 $2.07 Million - $3.63 Million
24,892 Added 10.4%
264,206 $38.5 Million
Q1 2022

May 16, 2022
BUY
$110.08 - $142.92 $20.2 Million - $26.2 Million
183,667 Added 330.06%
239,314 $28.4 Million
Q4 2021

Feb 14, 2022
BUY
$99.73 - $148.48 $5.55 Million - $8.26 Million
55,647 New
55,647 $7.67 Million

Others Institutions Holding BHVN

# of Institutions
11
Shares Held
792K
Call Options Held
0
Put Options Held
0
View Full List

About Biohaven Pharmaceutical Holding Co Ltd.

BHVN Quotes by TradingView
  • Ticker BHVN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,645,000
  • Market Cap $2.8B
  • Description
  • Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...
More about BHVN
Track This Portfolio

Track Fairmount Funds Management LLC Portfolio

Follow Fairmount Funds Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fairmount Funds Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fairmount Funds Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email